What Is Cardlytics, Inc. Common Stock (CDLX) Worth in 2026?
According to the CirclFi Deep Alpha Valuation Engine, Cardlytics, Inc. Common Stock's intrinsic value is estimated at $13.45, suggesting a +212.9% average upside from the current price of $4.30. While 5 models see room for appreciation, model agreement is not unanimous as 2 models flag potential overvaluation. Model dispersion is worth noting: CUCE targets $21.94 (+410.3%), versus First Chicago at $0.08 (-98.2%). This +508.5% range highlights the importance of multi-model analysis rather than relying on any single methodology.
What Do the Models Say About CDLX?
7 of 13 models are currently active for CDLX. Of these, 5 models suggest upside while 2 models suggest overvaluation. The Bayesian DCF estimates CDLX's intrinsic value at $0.81, implying -81.1% downside from the current price. See which stocks rank higher →
How Does CDLX Rank in Services-Computer Programming, Data Processing, Etc.?
Among 75 Services-Computer Programming, Data Processing, Etc. stocks, CDLX ranks #60 by Quality of Company score. CirclFi's QOC score of 4.8/10 evaluates 32 fundamental signals. A score of 4.8 reflects mixed fundamentals.
See all Most Undervalued Services-Computer Programming, Data Processing, Etc. Stocks →
Cardlytics, Inc. Common Stock operates in a competitive landscape where fundamental quality metrics are key differentiators for long-term value creation.
Is CDLX a Value Trap?
CirclFi's Value Trap algorithm assigns CDLX a score of 30/100 (LOW). This indicates low risk. The financial profile does not exhibit typical value trap warning signs. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →
Multi-Model Methodology
7 of 13 models are active for Cardlytics, Inc. Common Stock. Moderate coverage provides meaningful perspective. Each model applies a fundamentally different valuation philosophy. See the complete methodology →
According to the CirclFi Quality of Company (QOC) framework, which evaluates 32 signals including margin stability, revenue growth trajectory, leverage, and free cash flow generation, Cardlytics, Inc. Common Stock is rated at 4.8/10. This moderate-tier score shows mixed signals across our quality framework with notable weaknesses.
The gap between the most bullish and bearish model spans +508.5% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →
Data Sources & Confidence
Every CDLX valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →
Across CDLX's 7 active models, average confidence is 30%. Lower confidence may reflect limited history or high volatility.
CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →